Page 125 of 160: studies 1,241 to 1,250 of 1,594, newest first. Back to the DMT overview
2019 17 citations
Researchers, program administrators, and practicing clinicians explain the most recent developments in using psychedelic substances to treat psychological, physiological, and social problems. More than a decade ago, the U.S. government lifted its ban on all testing of psychedelic substances. Winkelman and Sessa now provide updated scientific research and applications of these substances, now...
Therapeutic Advances in Psychopharmacology 2019 Juliana Mendes Rocha, Flávia de Lima Osório, José Alexandre S. Crippa et al. 44 citations
Background: Recognition of emotions in facial expressions (REFE) is a key aspect of social cognition. Anxiety and mood disorders are associated with deficits in REFE, and anxiolytics and antidepressants reverse these deficits. Recent studies have shown that serotonergic hallucinogens (i.e. ayahuasca, dimethyltryptamine, psilocybin, lysergic acid diethylamide [LSD], and mescaline) have...
Journal of Psychoactive Drugs December 22, 2018 Sueli Moreira Mello, Paula Christiane Soubhia, Gabriela de Oliveira Silveira et al. 15 citations
Ayahuasca is a beverage obtained from decoctions of the liana Banisteriopsis caapi plus the shrub Psychotria viridis. This beverage contains a combination of monoamine oxidase inhibitors (harmine, harmaline, and tetrahydroharmine) and N,N-dimethyltryptamine, the main substance responsible for its visionary effect. The ritualistic use of ayahuasca is becoming a global phenomenon. Most members of...
Environmental and Molecular Mutagenesis November 29, 2018 Fábio Kummrow, Bianca S. Maselli, Rafael Lanaro et al. 9 citations
Ayahuasca is a beverage used in religious rituals of indigenous and nonindigenous groups, and its therapeutic potential has been investigated. Ayahuasca is obtained by decoction of the Banisteriopsis caapi that contains β‐carbolines (harmine, harmaline, and tetrahydroharmine) plus Psychotria viridis that contains N , N ‐dimethyltryptamine. Although plants used in folk medicine are recognized as...
Drug Testing and Analysis November 21, 2018 Katharina Elisabeth Grafinger, Andreas Wilke, Stefan König et al. 15 citations
Abstract Tryptamines can occur naturally in plants, mushrooms, microbes, and amphibians. Synthetic tryptamines are sold as new psychoactive substances (NPS) because of their hallucinogenic effects. When it comes to NPS, metabolism studies are of crucial importance, due to the lack of pharmacological and toxicological data. Different approaches can be taken to study in vitro and in vivo...
Phytochemistry November 2018 Gabrielle Macedo Pereira, Letícia Gondim Lambert Moreira, Themístocles da Silva Negreiros Neto et al.
Stem bark, root bark, and leaf extracts of Erythroxylum pungens were subjected to phytochemical analysis. N,N-dimethyltryptamine (DMT) was isolated and characterized from E. pungens roots. This unprecedented result is remarkable since no indole alkaloid has been previously reported from Erythroxylaceae so far. Eleven known tropane alkaloids were identified by their mass spectra and...
Neuropharmacology November 2018 Edward M. Sellers, Myroslava K. Romach, Deborah B. Leiderman
Scientific curiosity and fascination have played a key role in human research with psychedelics along with the hope that perceptual alterations and heightened insight could benefit well-being and play a role in the treatment of various neuropsychiatric disorders. These motivations need to be tempered by a realistic assessment of the hurdles to be cleared for therapeutic use. Development of a...
Marine Drugs October 26, 2018 Mohamed A. Ibrahim, Abir T. El-Alfy, Kelly Ezel et al. 22 citations
In previous studies, we have isolated several marine indole alkaloids and evaluated them in the forced swim test (FST) and locomotor activity test, revealing their potential as antidepressant and sedative drug leads. Amongst the reported metabolites to display such activities was 5-bromo-N,N-dimethyltryptamine. Owing to the importance of the judicious introduction of halogens into drug...
Journal of Clinical Psychopharmacology October 19, 2018 Rafael G. Dos Santos, José Alexandre S. Crippa, Flávia de Lima Osório et al. 9 citations
dos Santos, Rafael Guimarães PhD; Crippa, José Alexandre MD, PhD; Osório, Flávia de Lima PhD; Rocha, Juliana M. BSc; Rossi, Giordano Novak BSc; Marchioni, Camila BSc; Queiroz, Maria Eugênia Costa PhD; Silveira, Gabriela O. BSc; Yonamine, Mauricio PhD; Hallak, Jaime Eduardo Cecilio MD, PhD Author Information
World Psychiatry September 7, 2018 Michaela Irwin, D. Piber
tial impact of psychedelic drugs on psychiatry to that of the microscope on biology and, while this analogy may strike some as laughable, let us reflect for a moment that human research with psychedelics has been effectively moribund since the restrictive drug policy reforms of the 1960s-70s, and has only recently been revived. Classic serotonergic psychedelics – such as LSD, psilocybin and...